The synthesis of 6′S-Me-2′-O,4′-C-ethylenebridged 5-methyluridine (6′S-Me-ENA-T) was achieved using visible light-mediated stereoselective radical cyclization as a key step. This is the first example of a method for constructing a 2′,4′-bridged structure from a 4′-carbon radical intermediate. The 6′S-Me-ENA-T monomer was successfully incorporated into oligonucleotides, and their properties were examined. The oligonucleotides containing 6′S-Me-ENA-T exhibited a highly selective hybridization affinity toward single-stranded RNA and an excellent enzymatic stability, compared to the corresponding LNA-and ENA-modified oligonucleotides.
Novel 2'-O,4'-C-ethylene-bridged nucleic acid (ENA) analogs with exocyclic methylene and (R)-methyl groups at the 6'position were synthesized. The obtained 6'-methylene-ENA and 6'R-Me-ENA were incorporated into oligonucleotides, and their properties were compared with those of the corresponding natural, ENA-, and 6'S-Me-ENA-modified oligonucleotides. The duplex-stabilizing ability of 6'-methylene-ENA and 6'R-Me-ENA with single-stranded RNA (ssRNA) was similar to that of ENA and 6'S-Me-ENA under both dilute and molecular crowding conditions. On the other hand, oligonucleotides containing 6'-methylene-ENA and 6'R-Me-ENA formed stable triplexes with double-stranded DNA (dsDNA) in comparison with those containing 6'S-Me-ENA. Their thermodynamic properties were also calculated to explore the influence of the substituents introduced at the 6'-position of ENA. Moreover, oligonucleotides with ENA analogs exhibited excellent resistance against nucleases. These results suggest that 6'-methylene-ENA and 6'R-Me-ENA are promising candidates for targeting ssRNA and dsDNA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.